JPM
JPMorgan Chase & Co.
JPM has slightly lower modeled downside risk, despite its lower overall score.
MC
Moelis & Company
MC has a slight edge over JPM overall, supported by stronger valuation and stronger modeled upside.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
MC Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
MC's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like MC.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM has the edge over MC in the historical PE scenario, which offers more potential upside but is not a forecast.
MC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 12x | $35.85 | -36% |
| Forward | 16x | $56.01 | — |
| Current | 19x | $56.01 | — |
| Fair | 20x | $60.15 | +7.4% |
| Expensive | 38x | $112 | +101% |
Historical ranges are pointers, not guarantees.
MC's PE is in its fair range at 19x. If earnings grow as analysts expect, today's price would be 16x next year's earnings.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
MC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Improving | |
| Limited | |
| Low |
MC has the edge over JPM on the outlook, with more favorable valuation expectations.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over MC on earnings, with more consistent year-over-year improvement.
MC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.55 | +21% |
| Q3 2026 | $2.94 | -1.7% |
| Q2 2026 | $2.87 | +13% |
| Q1 2026 | $2.78 | +28% |
| Q4 2025 | $2.94 | +67% |
| Q3 2025 | $2.99 | +464% |
| Q2 2025 | $2.54 | +1593% |
| Q1 2025 | $2.18 | +$2.37 |
| Q4 2024 | $1.76 | +$2.12 |
MC's earnings per share have fallen from their peak: $2.94 over the past year, against $5.90 in late 2021.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over MC on profitability, with a higher operating margin.
MC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $409.4M | +12% |
| Q1 2026 | $319.8M | +4.3% |
| Q4 2025 | $487.9M | +11% |
| Q3 2025 | $356.9M | +30% |
| Q2 2025 | $365.4M | +38% |
| Q1 2025 | $306.6M | +41% |
| Q4 2024 | $438.7M | +104% |
| Q3 2024 | $273.8M | +0.6% |
MC has the edge over JPM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 18% | +1.2 points |
| Q1 2026 | 13% | +0.6 points |
| Q4 2025 | 26% | -3.8 points |
| Q3 2025 | 14% | +7.8 points |
| Q2 2025 | 17% | +9 points |
| Q1 2025 | 12% | +9.4 points |
| Q4 2024 | 30% | +34 points |
| Q3 2024 | 5.7% | +13 points |
MC's operating margin was 18% last quarter, up 1.2 points from the same quarter a year ago.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
MC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $250.2M | +39% |
| Q2 2026 | $218M | +9.3% |
| Q1 2026 | -$291.6M | -$123M |
| Q4 2025 | $329.6M | +5.3% |
| Q3 2025 | $179.6M | +33% |
| Q2 2025 | $199.4M | +45% |
| Q1 2025 | -$168.6M | +$1.8M |
| Q4 2024 | $313M | +233% |
MC has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over MC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
MC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.7% | -1.4M shares |
| 1 year | -1.3% | -994K shares |
| 3 years | +14% | +9.3M shares |
| 5 years | +14% | +9.8M shares |
| Available history | +39% | +21.7M shares |
MC has 78M diluted shares, down 1.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | $23.5M |
| Q1 2026 | $117.3M |
| Q4 2025 | $46.1M |
| Q3 2025 | $15.2M |
| Q2 2025 | $1.6M |
| Q1 2025 | $11.6M |
| Q4 2024 | $1.1M |
| Q3 2024 | $1M |
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
MC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.4x | Very low |
| Q4 2025 | -0.8x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | 0.2x | Very low |
| Q4 2024 | -1.0x | Net Cash |
MC has the edge over JPM on leverage, with a lower net debt burden relative to earnings.
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
MC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.7 | Neutral |
| Stochastic | 30.3 | Neutral |
MC's weekly RSI is 39 (neutral) and its Stochastic is 30 (neutral).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM has the edge over MC on valuation relative to its sector.
MC PE vs Financial Services Sector
| Metric | MC | Sector median | Relative |
|---|---|---|---|
| PE | 19x | 13x | 46% above |
| PE % | 44 | 63 | 19 pts below |
MC is trading at 19x earnings, a 46% premium to the Financial Services sector's median of 13x.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over MC on trend strength, trading above more of its moving averages.
MC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $56.6 | 1% below |
| 20 week MA | $62.6 | 10% below |
| 50 week MA | $64.5 | 13% below |
| 100 week MA | $65.3 | 14% below |
| 200 week MA | $59.0 | 5.1% below |
MC is in a downtrend: it's below all five of its weekly moving averages, and 5.1% below its 200-week average.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over MC on returns for 2026, with the stronger performance.
MC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $32.8 | $47.2 | +44% |
| 2021 | $47.2 | $62.4 | +32% |
| 2022 | $62.4 | $39.0 | -37% |
| 2023 | $39.0 | $56.1 | +44% |
| 2024 | $56.1 | $74.5 | +33% |
| 2025 | $74.5 | $71.6 | -3.9% |
| 2026 YTD | $71.6 | $56.0 | -22% |
MC has finished higher in four of the last six years. It's down 22% so far in 2026.